• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

MedPanel Launches Profiles in Non-Hodgkin's Lymphoma -- United States & Europe

Posted on: Thursday, 12 January 2006, 12:00 CST

CAMBRIDGE, Mass., Jan. 12 /PRNewswire/ -- MedPanel, a leader in online medical market intelligence, announces the launch of Profiles in Non-Hodgkin's Lymphoma -- United States & Europe, the second release in its 2005-2006 Profiles in Oncology series. Profiles is a subscription service delivering four highly detailed, cancer-specific studies on a quarterly basis. Profiles studies evaluate clinical and commercial market opportunities for both current and emerging oncology products. Profiles is designed to provide in-depth analysis for organizations and companies considering the development, acquisition or launch of a novel therapeutic agent. The studies explore best practices, key outcomes measures, unmet medical needs, and future direction of treatment for a given indication while quantifying the trade-offs associated with varying levels of clinical performance on an agent-specific basis. The latest study offers analysis of treatment of both indolent and aggressive forms of the disease.

The incidence of non-Hodgkin's lymphoma has increased dramatically in recent decades. The disease has gone from being relatively rare to being the fifth most common cancer in the United States. During this period, incidence rates have increased up to five percent per year. According to Surveillance Epidemiology and End Results (SEER) data and American Cancer Society (Cancer Facts and Figures) data, in the United States, the incidence of non-Hodgkin's lymphoma is approximately 55,000 cases annually. In Europe, the figures are similar. France, Germany, Italy, Spain, and the United Kingdom have among the largest numbers of cases in the world. At present, there is little explanation for the increase, and little is known about the underlying cause of the disease. These statistics highlight the continued need for enhanced diagnostic techniques and improved therapeutic strategies for non-Hodgkin's lymphoma.

"The insights contained in Profiles in Non-Hodgkin's Lymphoma -- United States & Europe should prove invaluable to drug makers as they attempt to develop agents with improved performance," said Matt Fearer, MedPanel's Senior Vice President of Content Development. "Because clients can manipulate the data housed in each Profiles study, they are able to quickly assess and quantify the impact of expected and -- perhaps more importantly -- unexpected clinical trial results and potential changes in their clinical development programs."

Dr. Nina Karlin, of UCLA, said, "In this era of molecular and individualized medicine, it is important to have interactive platforms that allow for the dissemination and exchange of information gathered in clinical trials. MedPanel expertly provides this platform by facilitating interactive discussions between community oncologists and thought leaders."

About MedPanel

MedPanel is a medical market intelligence company providing custom and syndicated medical market research exclusively online. MedPanel's powerful proprietary methodology and platform enable pharmaceutical, biotechnology, medical device, diagnostics companies, as well as others with an interest in life sciences, to have greater strategic control over the development and commercialization of products, and lower costs overall. Through unparalleled access to clinicians, medical thought leaders and healthcare professionals, and through its interactive, asynchronous approach to medical panels and surveys, MedPanel is able to deliver fast, unbiased, cost-effective and actionable data. MedPanel is a global organization based in Cambridge, Massachusetts.

For more information on Profiles, contact Jim Patton at 617.661.8080 x321, or email jim.patton@medpanel.com.

Website: http://www.medpanel.com/ /

MedPanel

CONTACT: Jim Patton of MedPanel, +1-617-661-8080, x321,jim.patton@medpanel.com

Web site: http://www.medpanel.com/

Source: PRNewswire

More News in this Category